Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE

Mid Cap | Pharmaceuticals & Drugs

942.55

3.35 (0.36%)

< Home < Back

Zydus Lifesciences Ltd. News

>>

Cadila Healthcare reports 54% rise in Q4 consolidated net profit

>>

Cadila Healthcare gains on launching Zolmitriptan in US market

>>

Cadila Healthcare launches Zolmitriptan in US market

>>

Cadila Healthcare loses Prevacid SoluTab patent infringement case v/s Takeda: Report

>>

Cadila gains on approving merger of its 3 subsidiaries with itself

>>

Cadila approves merger of its 3 subsidiaries with itself

>>

Cadila Healthcare informs about Board Meeting

>>

Zydus Cadila gains on receiving tentative approval from USFDA for Amlodipine Besylate, Benazepril Hydrochloride

>>

Zydus Cadila receives tentative approval from USFDA for Amlodipine Besylate, Benazepril Hydrochloride

>>

Cadila Healthcare gains on the buzz of its plans of launching molecule for diabetes dyslipidemia

<< < 163 164 165 ...168 > >>